Fluoroquinolone Antibacterial [EPC]

This page covers all Fluoroquinolone Antibacterial [EPC] drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Multidrug and toxin extrusion protein 1, CAAX prenyl protease 2, Multidrug and toxin extrusion protein 1, Potassium voltage-gated channel subfamily H member 2.

Targets

Multidrug and toxin extrusion protein 1 · CAAX prenyl protease 2, Multidrug and toxin extrusion protein 1, Potassium voltage-gated channel subfamily H member 2

Marketed (3)

• Levaquin · Santen
  Levaquin works by inhibiting bacterial DNA replication and transcription by binding to the enzyme DNA gyrase.
• Baxdela · Melinta · Infectious Disease
  Baxdela works by blocking bacterial enzymes that replicate DNA.
• Levaquin · Generic (originally Daiichi Sankyo/J&J) · Infectious Disease
  Levofloxacin is a fluoroquinolone antibacterial agent.

Patent intelligence

• fluoroquinolone antibacterial patent landscape — aggregated cliff calendar, attackable patents, originator estates